World News
-
Boehringer Ingelheim partners with Zai Lab for dual-targeting lung cancer trial
The Phase Ib/II trial will assess safety, tolerability, and early signs of clinical activity. Researchers will combine Boehringer Ingelheim’s investigational T-cell engager, obrixtamig, with Zai Lab’s antibody-drug conjugate (ADC), zocilurtatug pelitecan (zoci).
-
Syntegon achieves record 2025 results as pharmaceutical innovation drives 22% growth
The company grew revenue by 10% to EUR 1.75 billion (USD1.91 billion) while substantially improving profitability and cash generation.
-
Daiichi Sankyo sells healthcare division to Suntory for USD1.6B in three phases
For Daiichi Sankyo, divesting this business allows the company to concentrate resources on its innovative medicines division, where it has emerged as a leader in antibody-drug conjugate (ADC) technology.
-
Philips gains FDA approval for AI-powered Spectral CT Innovation in United States
The Verida system represents a leap forward in CT imaging, incorporating Philips’ third-generation Nano-panel Precise dual-layer detector alongside an AI-driven deep learning reconstruction engine.
-
Roche initiates new phase 3 trial to secure European approval for Elevidys
The European Medicines Agency rejected Elevidys for ambulatory patients last year, citing insufficient evidence of effectiveness.
-
AWS launches “Amazon Bio Discovery” to revolutionize antibody research
The platform offers a comprehensive suite of tools, including a library of AI models, advanced analytics packages, and an AI-powered agent that assists researchers in designing experiments.
-
Eli Lilly to acquire CrossBridge Bio in USD300M deal to advance next-generation cancer therapies
CrossBridge Bio plans to submit an Investigational New Drug (IND) application for CBB-120, positioning the candidate for clinical development.
-
UK’s MHRA approves single-injection 7.2mg Wegovy pen for obesity management
The approval specifically applies to adults diagnosed with obesity and does not extend to individuals who are overweight with a BMI below 30kg/m² using Wegovy for weight management.
-
Gan & Lee Pharmaceuticals expands Bofanglutide to South Korea with JW Pharmaceutical partnership
The collaboration leverages JW Pharmaceutical’s established research and development capabilities to accelerate the drug’s entry into South Korea’s growing metabolic disease sector.
-
Stryker acquires Amplitude Vascular Systems to enter high-growth IVL market
AVS has developed the Pulse IVL system, which uses pressurised sound waves delivered through a balloon catheter to remove calcium deposits in patients with calcified peripheral artery disease (PAD).